1. Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. (25th October 2015) Authors: Szebeni, J; Fishbane, S; Hedenus, M; Howaldt, S; Locatelli, F; Patni, S; Rampton, D; Weiss, G; Folkersen, J Journal: British journal of pharmacology Issue: Volume 172:Number 21(2015:Nov.) Page Start: 5025 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses. Issue 6 (1st December 2001) Authors: Kruis, W; Schreiber, S; Theuer, D; Brandes, J-W; Schütz, E; Howaldt, S; Krakamp, B; Hämling, J; Mönnikes, H; Koop, I; Stolte, M; Pallant, D; Ewald, U Journal: Gut Issue: Volume 49:Issue 6(2001) Page Start: 783 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Oral 4-aminosalicylic acid versus 5-aminosalicylic acid slow release tablets. Double blind, controlled pilot study in the maintenance treatment of Crohn's ileocolitis. Issue 8 (August 1994) Authors: Schreiber, S; Howaldt, S; Raedler, A Journal: Gut Issue: Volume 35:Issue 8(1994) Page Start: 1081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P331 Productivity loss in patients with inflammatory bowel disease receiving treatment for iron deficiency anaemia: A comparison of ferric maltol and IV iron. (15th January 2020) Authors: Howaldt, S; Jacob, I; Sampson, M; Akriche, F Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P420 Comparative efficacy and safety of oral ferric maltol in Inflammatory Bowel Disease patients with mild-to-moderate vs. more severe iron deficiency anaemia. (27th May 2021) Authors: Akriche, F; Jacob, I; Schmidt, C; Howaldt, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S424 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P478 Treatment with ferric maltol associated with improvements in quality of life for IBD patients with iron deficiency anaemia. (16th January 2018) Authors: Schmidt, C; Baumgart, D; Bokemeyer, B; Büning, C; Howaldt, S; Stallmach, A; Singfield, C; Tremblay, G; Jones, T Journal: Journal of Crohn's and colitis Issue: Volume 12:Number 1(2018:Jan.)Supplement 1 Page Start: S346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P543 Induction and maintenance of mucosal healing in Crohn's disease with ustekinumab in clinical practice – Results of a nationwide, prospective, multicenter study in Germany (MUCUS). (30th January 2023) Authors: Baumgart MD PhD MBA, D C; Stallmach, A; Schubert, A; Howaldt, S; von Arnim, U; Ochsenkühn, T; Stein, J; Lügering, A; Schmidt, D; Schulz, M; Fischer, A Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i669 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P567 Impact of oral ferric maltol and IV iron on health-related quality of life in patients with iron deficiency anaemia and inflammatory bowel disease, and relationship with haemoglobin and serum iron. (15th January 2020) Authors: Howaldt, S; Jacob, I; Sampson, M; Akriche, F Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P592 Costs savings associated with ferric maltol and the reduced use of intravenous iron based on real world data. (27th May 2021) Authors: Howaldt, S; Becker, C K; Becker, J A; Poinas, A C Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S541 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P685 Healthcare resource use associated with ferric maltol and IV iron treatment for iron deficiency anaemia in patients with inflammatory bowel disease. (15th January 2020) Authors: Howaldt, S; Jacob, I; Sampson, M; Akriche, F Journal: Journal of Crohn's and colitis Issue: Volume 14(2020)Supplement 1 Page Start: S558 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗